Moberg Pharma AB (publ) (MOB) — Cash Flow Reinvestment Rate
Moberg Pharma AB (publ) (MOB) has a Cash Flow Reinvestment Rate of 1.00x as of December 2025, reinvesting Skr1.52 Million (capex Skr1.52 Million ) from operating cash flow of Skr1.52 Million. Explore Moberg Pharma AB (publ) capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Moberg Pharma AB (publ) Cash Flow Reinvestment Rate (2012–2019)
Historical reinvestment intensity for Moberg Pharma AB (publ) across 6 annual periods. Also explore MOB asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Moberg Pharma AB (publ) (2012–2019)
Year-by-year capital reinvestment analysis for Moberg Pharma AB (publ). For live market cap and broader valuation context, see market value of Moberg Pharma AB (publ).
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.73x | Skr2.87 Million | Skr3.95 Million | Skr2.87 Million | ▼ -67.9% |
| 2018 | 2.26x | Skr167.28 Million | Skr73.89 Million | Skr83.64 Million | ▲ +209.6% |
| 2017 | 0.73x | Skr39.35 Million | Skr53.82 Million | Skr19.68 Million | ▼ -48.8% |
| 2015 | 1.43x | Skr43.88 Million | Skr30.72 Million | Skr43.88 Million | ▲ +217.5% |
| 2014 | 0.45x | Skr7.27 Million | Skr16.16 Million | Skr7.27 Million | ▲ +576.8% |
| 2012 | 0.07x | Skr630.00K | Skr9.48 Million | Skr630.00K | — |